diego

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,…

2 weeks ago

FASHIONPHILE Announces Martha Stewart as its 2025 Holiday Brand Ambassador

The ultra-luxury re-commerce platform taps entrepreneur, author and media personality as the face of its 2025 Holiday campaign alongside a…

3 weeks ago

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

October 24, 2025 07:02 ET  | Source: Kura Oncology, Inc. - Milestone triggered by dosing of first patient in frontline…

1 month ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx  Constellation outperformed orthogonal methods in…

1 month ago

The Capital Link Announces Investigation Into the LuxUrban Story – The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up

San Diego, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The Capital Link is proud to spotlight a powerful investigative feature from Legal…

2 months ago

SDSU Athletics Partners with Cybersecurity Leader ESET to Champion Student-Athlete Success On and Off the Field

SAN DIEGO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- San Diego State University (SDSU) Athletics has named ESET, a global cybersecurity…

2 months ago

AppFolio Ignites the Next Era of Real Estate at FUTURE 2025

SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- AppFolio (NASDAQ:APPF), the technology leader powering the future of the real estate…

3 months ago

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…

3 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

3 months ago